KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Charles River Laboratories International's Total Current Liabilities rose 1083.43% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1083.43%. This contributed to the annual value of $994.1 million for FY2024, which is 577.97% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Total Current Liabilities of $1.1 billion as of Q3 2025, which was up 1083.43% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Total Current Liabilities ranged from a high of $1.1 billion in Q3 2025 and a low of $803.4 million during Q1 2021
  • In the last 5 years, Charles River Laboratories International's Total Current Liabilities had a median value of $1.0 billion in 2023 and averaged $1.0 billion.
  • Per our database at Business Quant, Charles River Laboratories International's Total Current Liabilities skyrocketed by 2770.49% in 2021 and then tumbled by 596.49% in 2024.
  • Charles River Laboratories International's Total Current Liabilities (Quarter) stood at $1.0 billion in 2021, then grew by 5.65% to $1.1 billion in 2022, then dropped by 3.34% to $1.1 billion in 2023, then fell by 5.78% to $994.1 million in 2024, then rose by 12.85% to $1.1 billion in 2025.
  • Its Total Current Liabilities was $1.1 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.